dr. A.D. Cornet

Functie: Intensivist - Internist
Bereikbaarheid: (06) 31 75 10 53
BIG Registratie: 89065009601


Dr. A.D. Cornet volgde zijn opleiding tot internist in het VU medisch centrum en het Sint Lucas Andreas Ziekenhuis in Amsterdam, waarbij hij ook een half jaar werkzaam was op de intensive care van het University College London Hospital in Groot Brittanië. De opleiding tot het aandachtsgebied intensive care volgde hij in het VU medisch centrum en rondde hij in 2014 af. In datzelfde jaar promoveerde hij op het proefschrift getiteld “The role of coagulopathy and blood transfusion in acute respiratory distress syndrome”. Sinds 2015 is hij werkzaam als intensivist in het MST.


  1. Cornet AD, Oudemans-van Straaten HM, Schultz MJ, Juffermans NP, Tuinman PR. Anticoagulants for ARDS: facts and future. Neth J Crit Care 2014;18:3-8
  2. De Wolf SP, Deunk J, Cornet AD, Elbers PW. Bilateral reexpansion pulmonary edema following treatment of a unilateral pneumothorax. F1000 Research 2014;3:318
  3. Cornet AD, Groeneveld AB, Hofstra JJ, Vlaar AP, Tuinman PR, van Lingen A, Levi M, Girbes AR, Schultz MJ, Beishuizen A. Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial. PLoS ONE 2014;9:e90983
  4. Tuinman PR, Cornet AD, Kuipers MT, Vlaar AP, Schultz MJ, Beishuizen A, Groeneveld AB, Juffermans NP. Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery. BMC Pulm Med 2013;13:76
  5. Cornet AD, Kooter AJ, Peters MJ, Smulders YM. The potential harm of oxygen therapy in medical emergencies. Crit Care 2013;17:313
  6. Cornet AD, Hofstra JJ, Vlaar AP, Tuinman PR, Levi M, Girbes AR, Schultz MJ, Groeneveld AB, Beishuizen A. Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome. J Thromb Haemost 2013;11:894-901
  7. Hofstra JJ, Cornet AD, Declerk PJ, Dixon B, Aslami H, Vlaar AP, Roelofs JJ, van der Poll T, Levi M, Schultz MJ. Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect lung injury. PLoS One 2013;8:e55262
  8. Cornet AD, Peters MJ, Kooter AJ. Letter by Cornet et al regarding article, “Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest”. Circulation 2012;125:e289
  9. Cornet AD, Kooter AJ, Peters MJ, Smulders YM. Supplemental oxygen therapy in medical emergencies: more harm than benefit? Arch Intern Med 2012;172:289-290
  10. Trof RJ, Beishuizen A, Cornet AD, de Wit RJ, Girbes AR, Groeneveld AB. Volume-limited versus pressure-limited hemodynamic management in septic and nonseptic shock. Crit Care Med 2012;40:1177-1185
  11. Vlaar AP, Cornet AD, Hofstra JJ, Parcelijn L, Beishuizen A, Kulik W, Vroom MB, Schultz MJ, Groeneveld AB, Juffermans NP. The effect of blood transfusion on pulmonary permeability in cardiac surgery patients: a prospective multicenter cohort study. Transfusion 2012;52:82-90
  12. Cornet AD, Vogel JJ, Karagozoglu KH, Thijs A. Cervical lump? The clue is in the hotspot. Lancet 2011;378:1438
  13. Cornet AD, Hofstra JJ, Vlaar AP, van den Boogaard FE, Roelofs JJ, van der Poll T, Levi M, Groeneveld AB, Schultz MJ. Nebulized anticoagulants limit coagulopathy but not inflammation in Pseudomonas aeruginosa-induced pneumonia in rats. Shock 2011;36:417-423
  14. Tuinman PR, Vlaar AP, Cornet AD, Hofstra JJ, Levi M, Meijers JC, Beishuizen A, Schultz MJ, Groeneveld JB, Juffermans NP. Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study. Crit Care 2011;15:R59
  15. Cornet AD, Thielen N, Kramer MH, Nanayakkara PW, Kooter AJ. Adult-onset Still’s disease and haemophagocytic syndrome. Ned Tijdschr Geneeskd 2010;154:A2528
  16. Cornet AD, Thijs A. Lorcaserine lijkt te werken bij de behandeling van overgewicht. Ned Tijdschr Geneeskd 2010;154:A2555
  17. Cornet AD, Zwart E, Kingma SD, Groeneveld AB. Pulmonary effects of red blood cell transfusion in critically ill, non-bleeding patients. Transfus Med. 2010;20:221-6
  18. Cornet AD, Juffermans NP. There is no place (yet) for routine administration of sildenafil to patients with ARDS. Intensive Care Med 2010;36:1104-1105
  19. Cornet AD, Hofstra JJ, Swart EL, Girbes AR, Juffermans NP. Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med. 2010;36:758-64
  20. Hofstra JJ, Vlaar AP, Cornet AD, Dixon B, Roelofs JJ, Choi G, van der Poll T, Levi M, Schultz MJ. Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a  model of experimental lung injury. J Aerosol Med Pulm Drug Deliv. 2010;23:105-11.
  21. Cornet AD, Girbes AR, Beishuizen A. Coagulopathy and ALI/ARDS. Ned Tijdschr Anesthesiologie 2010;22:29-31
  22. Hofstra JJ, Cornet AD, de Rooy BF, Vlaar AP, van der Poll T, Levi M, Zaat SA, Schultz MJ. Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats. Crit Care. 2009;13(5):R145.
  23. Cornet AD, Kingma SD, Trof RJ, Wisselink W, Groeneveld AB. Hepatosplanchnic ischemia/reperfusion is a major determinant of lung vascular injury after aortic surgery. J Surg Res. 2009;157:48-54
  24. Cornet AD, van Nieuw Amerongen GP, Beishuizen A, Schultz MJ, Girbes ARJ, Groeneveld ABJ. Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Drug Discov 2009;4:219-227
  25. Cornet AD, Beishuizen A, Groeneveld AB. Activated Protein C in sepsis: tightening pulmonary endothelial cells? Crit Care Med 2007;35:2656-2658.
  26. Cornet AD, Klein LJ, Groeneveld AB. Coronary stent occlusion after platelet transfusion: a case series.  J Invasive Cardiol 2007;19:E297-299.
  27. Cornet AD, Smit EG, Beishuizen A, Groeneveld AB. The role of heparin and allied compounds in the treatment of sepsis. Thromb Haemost 2007;98:579-586.
  28. Cornet AD, Issa AI, van de Loosdrecht AA, Ossenkoppele GJ, Strack van Schijndel RJ, Groeneveld AB. Sequential organ failure predicts mortality of patients with a haemato-oncological malignancy needing intensive care. Eur J Haematol 2005;74:511-516.
Waar bent u naar op zoek?